by NavigoProteins | Apr 1, 2025 | Press
HALLE, Germany and MOL, Belgium, 01.04.2025 Navigo Proteins GmbH, a leader in precision medicine and next-generation radiotheranostics, today announced a strategic research collaboration with SCK CEN, the Belgian Nuclear Research Centre. This partnership will focus on...
by NavigoProteins | Dec 12, 2024 | Press
HALLE and HEIDELBERG, Germany, December 12, 2024 Navigo Proteins GmbH, an innovator developing next-generation targeted radiotheranostics, and VERAXA Biotech AG, an emerging leader in designing novel cancer therapies, announced today the initiation of a research...
by NavigoProteins | Nov 25, 2024 | Precision Capturing Blog
Scientists continuously face pressure to purify biologics like protein therapeutics with maximum yield while minimizing cost and developing processes as quickly as possible. Downstream processing often accounts for more than half the cost of goods overall and...
by NavigoProteins | Nov 25, 2024 | Precision Capturing Blog
Scientists continuously face pressure to purify biologics with maximum yield while minimizing cost and developing processes as quickly as possible. Downstream processing (DSP) often accounts for more than half the cost of goods overall and significantly impacts...
by NavigoProteins | Nov 25, 2024 | Precision Capturing Blog
Protein A is no longer just for antibody purification. Precision Capturing® covers both affinity chromatography for recombinant protein purification and monoclonal antibody purification under the platform names Precision X® and Precision A®. Antibodies have set the...
Recent Comments